Copyright
©The Author(s) 2021.
World J Diabetes. Mar 15, 2021; 12(3): 292-305
Published online Mar 15, 2021. doi: 10.4239/wjd.v12.i3.292
Published online Mar 15, 2021. doi: 10.4239/wjd.v12.i3.292
Table 4 Comparison of Pittsburgh Sleep Quality Index scores and glycosylated hemoglobin values between the intervention and control groups
| Variable | Baseline | 2 mo | 6 mo | 12 mo | Significance level | ||||||
| CBT | UC | CBT | UC | CBT | UC | CBT | UC | Condition | Time | Interaction | |
| PSQI score | 10.07 (2.38) | 10.04 (2.37) | 9.35 (2.79) | 9.99(2.41) | 9.42 (2.75) | 9.92 (2.54) | 9.01 (2.67) | 9.91 (2.34) | < 0.001 | < 0.001 | < 0.001 |
| HbA1c value | 7.44 (1.12) | 7.50 (1.13) | 7.46 (1.10) | 7.50 (1.15) | 7.27 (1.18) | 7.44 (1.20) | 7.22 (1.14) | 7.52 (1.12) | < 0.001 | 0.001 | < 0.001 |
- Citation: Zhang HZ, Zhang P, Chang GQ, Xiang QY, Cao H, Zhou JY, Dong ZM, Qiao C, Xu CR, Qin Y, Lou PA. Effectiveness of cognitive behavior therapy for sleep disturbance and glycemic control in persons with type 2 diabetes mellitus: A community-based randomized controlled trial in China. World J Diabetes 2021; 12(3): 292-305
- URL: https://www.wjgnet.com/1948-9358/full/v12/i3/292.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i3.292